The independent source for health policy research, polling, and news.
29,441 - 29,460 of 112,460 Results
An FDA advisory panel gave the green light to the drug, which treats epilepsy, and the full agency is expected to give its approval, as well, sometime in June.
The Washington Post takes a look at the impression Dr. Ronny Jackson has made on colleagues during his tenure serving as a White House physician under three presidents.
The program had provided more than $100 million a year to 81 groups and institutions serving about 1.2 million teens, but the administration abruptly cut off grants last year, arguing that the programs were ineffective at curbing teenage pregnancy.
In a turnaround from previous elections, Republicans are ducking the topic that now fires up the Democratic base more so than the conservative one.
Anti-abortion lawmakers are hoping to get legislation in the pipeline to trigger a legal challenge for Roe v. Wade.
Today's early morning highlights from the major news organizations.
Editorial pages focus on these and other health topics.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from D.C., California, Texas, Iowa, Louisiana, Wisconsin, Florida, Puerto Rico, Georgia, Ohio, Arizona, Minnesota and Illinois.
Scientists have figured out a way to make cells turn dark like a tattoo when calcium levels in the blood is too high. In other public health news: gene therapy, concussions, categorizing sounds, homeopathic remedies, and autism.
Touted as a "breakthrough" discovery, a new paper challenges the traditional belief that keeping the liver cool while transporting it from donor to recipient will slow the dying process.
Early detection is key, researchers say, and spouses play an important role by spotting unusual looking moles and encouraging visits to dermatologists.
The lag it takes to get back on Medicaid can mean relapses or other serious problems for prisoners struggling with addiction or mental health issues. "On the outside, if they didn't get their treatment, they'd come right back through the front door again," New Hampshire Department of Corrections Superintendent David Dionne says.
The Justice Department’s antitrust chief, Makan Delrahim, has taken a tough stand against similar types of deals in the past.
Drugmakers are expecting to take a financial hit from the copay accumulator programs that PBMs have begun marketing. And the Supreme Court may review a whistleblower case that could have implications across the pharmaceutical industry.
HHS Secretary Alex Azar has been dealing with diverticulitis, a condition where pouches form in the colon wall and can become inflamed or infected.
Advocates say it's hard to get lawmakers to focus on the issue of up to 900 maternal deaths annually in the U.S. when their attention is on the opioid crisis. “We think this is an issue that touches enough American families that it ought to get the same attention," said Dr. Neel Shah, vice president of March for Moms.
The measure would kick off a five-year study on the safety and efficacy of marijuana. “As a physician, I’m keenly aware of the need to look for opioid alternatives to treat patients’ chronic pain,” said Rep. Phil Roe (R-Tenn.), the chairman of the Veterans’ Affairs Committee.
In an abrupt shift, the National Institutes of Health said it won't take money from the pharmaceutical industry, and will instead fund the study exclusively through taxpayer dollars. In other news on the crisis: a look at the U.S. Public Health Service's Commissioned Corps, a 6,500-strong group of health experts fighting the epidemic; how the surgeon general's advice for Americans to carry naloxone will play out; more states are taking the fight against drugmakers to the courts; and more.
Lawmakers are urging HHS to take steps to bring down the price of the antioverdose medication. Meanwhile, in an election year, Sen. Claire McCaskill (D-Mo.) can't find Republicans to back her bill to crack down on suspicious opioid shipments, and other lawmakers seek $100 billion to fight the crisis over the next 10 years.
© 2026 KFF